Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Queen's University (Kingston, Ontario)

$684,585.00

Calcitriol and Vitamin K Co-Treatment in CKD: Targeting Vascular Calcification

EF 2013-14

Résumé
In chronic kidney disease, the leading cause of death is cardiovascular disease (CVD). One major problem is vascular calcification- the formation of bone-like crystals in the blood vessel walls. Our study will examine the effects that the amounts of vitamin D and K as well as the mineral phosphate in the body have upon the blood vessels in CKD. Kidney disease patients have vitamin D and K deficiency. However, some studies suggest that excess vitamin D promotes VC. We want to find out how vitamin D, along with vitamin K, affects this process. We will explore how too much and too little vitamin D or K result in blood vessel calcification. We will also see how too much phosphate can change the way these vitamins work. These studies will be done using a rat animal model of kidney disease. We will change the amounts of vitamins D, K, and phosphate in the diets of animals with chronic kidney disease. We will then measure the amount of calcium and phosphate in blood vessels, hearts, and tissues in these animals as well as the gene expression of key proteins involved in vascular calcification as well as vitamin D and K metabolism. This will help provide an understanding in the roles of vitamin D and K as well as phosphate in the progress of vascular calcification in chronic kidney disease. This could pave the way to new treatments and recommendations for people suffering from this disease.
Programme
Operating Grant
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
292188
Name
Holden Rachel M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
Calcitriol and Vitamin K Co-Treatment in CKD: Targeting Vascular Calcification
Programtype2
Operating Grants
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$684,585
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Calcitriol; Cardiovascular Disease; Chronic Kidney Disease; Circulation; Experimental Animals; Vascular Calcification; Vitamin K
Abstract
In chronic kidney disease, the leading cause of death is cardiovascular disease (CVD). One major problem is vascular calcification- the formation of bone-like crystals in the blood vessel walls. Our study will examine the effects that the amounts of vitamin D and K as well as the mineral phosphate in the body have upon the blood vessels in CKD. Kidney disease patients have vitamin D and K deficiency. However, some studies suggest that excess vitamin D promotes VC. We want to find out how vitamin D, along with vitamin K, affects this process. We will explore how too much and too little vitamin D or K result in blood vessel calcification. We will also see how too much phosphate can change the way these vitamins work. These studies will be done using a rat animal model of kidney disease. We will change the amounts of vitamins D, K, and phosphate in the diets of animals with chronic kidney disease. We will then measure the amount of calcium and phosphate in blood vessels, hearts, and tissues in these animals as well as the gene expression of key proteins involved in vascular calcification as well as vitamin D and K metabolism. This will help provide an understanding in the roles of vitamin D and K as well as phosphate in the progress of vascular calcification in chronic kidney disease. This could pave the way to new treatments and recommendations for people suffering from this disease.
Competitiondate
201309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Holden, Rachel M; Adams, Michael A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $684,585~ $0~